UCSD trio, Salk's Fred Gage get new stem-cell grants

City News Service

Three researchers at UCSD were awarded about $5.6 million in grants Thursday aimed at funding efforts to remove technological

barriers to moving stem-cell research projects into clinical trials.

The board also decided to fund an Early Translational Award II to Fred Gage at the Salk Institute that had been held over from the October board meeting. The award includes international collaborators in Germany. The portion of the projects carried out by the collaborator will be funded by the Federal Ministry of Education and Research (BMBF), the science ministry in Germany, which will provide approximately $600,000 toward the project.

The California Institute for Regenerative Medicine awarded nearly $33 million in grants to 19 researchers across the state. CIRM was established in November 2004 as the state's stem cell agency, thanks to voters' passage of Proposition 71.

“These awards are a crucial component of CIRM's commitment to accelerate the development of stem cell-based therapies for people of the world,” CIRM President Alan Trounson said. “CIRM funds all stages of therapy development, from basic research to translational awards, but any of these could be stalled by technological bottlenecks. In funding these innovative tools and technologies, CIRM is removing those barriers before they can delay cures.”

Among the grant recipients announced were UC San Diego researchers Lawrence Goldstein, Karl Willert and Shu Chien. Goldstein and Chen each received about $1.8 million, while Goldstein was awarded about $2 million.



Be relevant, respectful, honest, discreet and responsible. Commenting Rules